Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest diabetes care Stories

2010-07-29 11:00:00

CLEVELAND, July 29 /PRNewswire/ -- With diabetes affecting the lives of hundreds of thousands of people throughout Ohio and Pennsylvania, Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical prescription holders. (Logo: http://photos.prnewswire.com/prnh/20100729/NE42933LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20100729/NE42933LOGO ) The program, which...

2010-07-29 11:00:00

PITTSBURGH, July 29 /PRNewswire/ -- With diabetes affecting the lives of hundreds of thousands of people throughout Pennsylvania and Ohio, Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical prescription holders. (Logo: http://photos.prnewswire.com/prnh/20100729/NE42933LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20100729/NE42933LOGO ) The program, which...

2010-07-29 04:15:00

FRANKLIN LAKES, N.J., July 29 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $1.878 billion for the third fiscal quarter ended June 30, 2010, representing an increase of 3.2 percent from the prior-year period, or 3.9 percent on a foreign currency-neutral basis. "We are pleased with our results this quarter, with each of our three segments contributing to our growth. We delivered...

2010-07-20 07:00:00

TARRYTOWN, N.Y., July 20 /PRNewswire/ -- As of January 1, 2010 the new performance certification standards applicable to devices that measure A1C (or glycated hemoglobin) as set by the National Glycohemoglobin Standardization Program (NGSP) changed to +/-0.75% A1C, 95% CI, 4-10.0% A1C range. Bayer Diabetes Care, manufacturer of A1CNow+® and A1CNow® SELFCHECK devices, submits for annual NGSP certification each June and has now successfully completed...

2010-07-12 11:00:00

PRINCETON, N.J., July 12 /PRNewswire/ -- Novo Nordisk Inc., a global healthcare company and leader in diabetes care, today announced the second issue of the Novo Nordisk BlueSheet, a resource for information on diabetes and chronic disease, highlighting key issues in diabetes prevention, detection, treatment and care. The second issue of the Novo Nordisk BlueSheet examines how insulin has evolved over the last 90 years, how it is developed today, the use of insulin devices in the U.S., and...

2010-06-30 15:40:00

ORLANDO, Fla., June 30 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, and Indy Lights race car driver Charlie Kimball today announced the availability of a wide array of resources to help kids with diabetes have a positive and rewarding summer camp experience. Kimball, who has type 1 diabetes, will hand out one of these resources today to attendees at the Children with Diabetes Friends for Life Conference in Orlando this week - the NovoLog® (insulin...

2010-06-26 10:30:00

ORLANDO, Fla., June 26 /PRNewswire/ -- An estimated 75 percent of adults with type 1 and type 2 diabetes say they believe they know what their blood sugar levels are without testing, according to data presented at the American Diabetes Association (ADA) 70th Scientific Sessions. These results are important to consider because self-monitoring with a blood glucose meter is essential for people with diabetes to obtain accurate blood sugar results that guide adjustments to meal planning,...

2010-06-26 09:00:00

ORLANDO, Fla., June 26, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced results from the first double-blind, placebo-controlled clinical study to evaluate BYETTA® (exenatide) injection added to Lantus® (insulin glargine), which showed patients with type 2 diabetes achieved glucose targets without weight gain or increasing their risk of hypoglycemia. These findings were...

2010-06-26 09:00:00

ORLANDO, Fla., June 26, 2010 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) today announced results from a study comparing the effect of long-term treatment with either BYETTA® (exenatide) injection or Lantus® (insulin glargine) on overall beta-cell function. (Beta cells are cells in the pancreas that produce insulin.) Three years of BYETTA therapy improved indices of beta-cell function...

2010-06-24 13:00:00

ALAMEDA, Calif., June 24 /PRNewswire-FirstCall/ -- Following the recent clearance of its FreeStyle Lite® blood glucose test strips, Abbott (NYSE: ABT) today announced that it has also received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new FreeStyle blood glucose test strips. The new FreeStyle test strips minimize interference during blood glucose testing and are designed to offer a better testing experience. In a similar fashion to the...


Latest diabetes care Reference Libraries

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

More Articles (1 articles) »